Showing results (11-20 of 77) with videos related to
Sort By:
Pageof 8
Cancer Biology & Therapy|December 7, 2016
Abscopal regression following SABR for non-small-cell-lung cancer: A case reportYang Cong, Ge Shen, Shikai Wu, et al.European Journal of Clinical Microbiology & Infectious Diseases : Official Publication of the European Society of Clinical Microbiology|February 11, 2023
A rare class A carbapenemase FRI-11 in Enterobacter clinical strainShikai Wu, Yanling He, Yu Feng, et al.Pathology Oncology Research : POR|September 25, 2023
Case report: Clinical experience of treating pembrolizumab-induced systemic capillary leak syndrome (SCLS) in one patient with metastatic gastroesophageal junction squamous cell carcinomaHua Ni, Xinjia Ding, Shikai Wu, et al.Scientific Reports|August 9, 2025
Real world effectiveness of chemotherapy plus bevacizumab with immunotherapy in colorectal cancerZhao Gao, Xiaoyan Wang, Tao Song, et al.Bulletin of Environmental Contamination and Toxicology|May 23, 2026
Economic Drivers of Microcystin Dynamics in Lakes of the Middle and Lower Reaches of the Yangtze River, ChinaShikai Wu, Liang Chen, Yubin Xing, et al.Oncotargets and Therapy|July 23, 2016
Combined treatment with everolimus and fulvestrant reversed anti-HER2 resistance in a patient with refractory advanced breast cancer: a case reportBing Sun, Lijuan Ding, Shikai Wu, et al.Cancer Biology & Therapy|October 30, 2020
Ototoxicity in patients with invasive ductal breast cancer who were treated with docetaxel: report of two casesLiang Xuan, Bing Sun, Xiangying Meng, et al.Oncotarget|August 11, 2016
Sunitinib as salvage treatment including potent anti-tumor activity in carcinomatous ulcers for patients with multidrug-resistant metastatic breast cancerBing Sun, Xin Zhao, Lijuan Ding, et al.Investigational New Drugs|August 17, 2023
Clinical characteristics of liver injury induced by immune checkpoint inhibitors in patients with advanced biliary tract carcinomaZhao Gao, Shikai Wu, Yinmo Yang, et al.Zhonghua Zhong Liu Za Zhi [Chinese Journal of Oncology]|December 18, 2002
[Clinical trial of lentaron for postmenopausal patients with advanced breast cancer]Xiaoqing Liu, Santai Song, Zefei Jiang, et al.Pageof 8